Materials and methods
Ethical approval. All of the experimental protocols and patient management procedures followed
the declaration of Helsinki and were approved by the Ethics Committees on Human Research of Anhui
Provincial Hospital, an affiliation of Anhui Medical University, Hefei, China (Notification Number: 2011
Ethics75). The couples consenting to participation in this study signed an informed consent form before
being enrolled.
Subject Information. The enrolled subjects (between 20 and 38 years of age; with tubal disorders
and/or a male factor) were IVF patients in the Reproductive Medicine Centre of Anhui Provincial
Hospital from February 2011 to October 2012. A total of 41 women who had biopsy-demonstrated
endometriosis and had undergone laparoscopic excision of minimal or mild endometriosis [stage I and
stage II endometriosis according to the revised classification of the American Fertility Society (R-AFS)]
were enrolled in this study (25 patients were enrolled in the TEM analysis, and 16 patients were enrolled
in the real time PCR analysis). In this study, the laparoscopy-based diagnosis of endometriosis required
the presence of one or more typical bluish or black lesions. The stages of endometriosis were determined
according to the R-AFS classification, including the implant and adhesion scores. The implant scores
were ranked according to the diameter and depth of the endometriotic implants on the peritoneum
or ovaries, whereas the adhesion scores were ranked according to the density and degree of enclosure.
Total R-AFS scores (implants and adhesions) from 1 to 5 and 6 to 15 correspond to minimal (stage I)
and mild (stage II) endometriosis, respectively. The patients underwent removal of the visible endome-
triotic implants by excision during laparoscopy. The exclusion criteria were recurrent cysts, polycys-
tic ovary syndrome, endometrioma, uterine adenomyosis and fibroids. Forty homochromous patients
without endometriosis detected by diagnostic laparoscopies having tube/male factor based infertility
were included as the control group (25 patients were enrolled in the TEM analysis and 15 patients were
enrolled in the real time PCR analysis).
Pituitary down regulation. For all of the patients, a standard long-term pituitary down-regulation
protocol was followed. Briefly, all of the patients received GnRH-a (Diphereline; Ipsen Pharma Biotech,
Signes, France) down-regulation from the mid-luteal phase of the preceding cycle of gonadotropin
(Gn: rFSH, Gonal-F , Merk Serono SA, Geneva, Switzerland) stimulation. The treatment strategy was
adapted, according to the ovarian response, followed by detection of the serum follicle stimulating hor -
mone (FSH), the luteinizing hormone (LH), and estradiol (E2) as well as transvaginal ultrasonography,
to evaluate whether the pituitary down-regulation was complete. After the pituitary down-regulation
was complete, r-FSH injections were initiated. Finally, follicle maturation was induced with 10,000 IU
of hCG (LiZhu Pharma, ZhuHai, China) 34–36 hours before oocyte retrieval (when at least 2 follicles
of18-mm or more than 3 follicles of 17-mm mean diameter were present). The decision on whether IVF
or intra-cytoplasmic sperm injection (ICSI) should be adopted for the patient was determined upon the
semen condition on the day of the oocyte retrieval.
Evaluation of oocytes by Transmission Electron Microscopy (TEM). A total of fifty mature
oocytes (MII) were included in this study. Twenty-five oocytes were collected from 25 patients with
minimal or mild endometriosis, and twenty-five oocytes were collected from 25 control women. The
oocytes were fixated for four hours following their collection and then processed for the TEM analysis,
as previously described
16. Ultrathin sections (60-80 nm) were cut with a diamond knife, mounted on a
copper grid and contrasted with saturated uranyl acetate followed by lead citrate before they were ana-
lysed and photographed (JEOL-1230 Transmission Electron Microscope).
www.nature.com/scientificreports/
3
Scientific RepoRts | 5:10779 | DOi: 10.1038/srep10779
Mitochondrial DNA copy, number determination by quantitative real-time PCR. Nineteen
mature (MII) oocytes from sixteen women with minimal to mild endometriosis and eighteen mature (MII)
oocytes from fifteen control women were prepared for analysis by quantitative real-time PCR. The cumu-
lus cells of the corona radiata were gradually removed using hand-pulled glass denudation pipettes. The
oocytes were washed in NaH
2PO4 (PH2.0) until the zona pellucidae dissolution. The oocytes were frozen
in liquid nitrogen for further analysis. The oocyte samples were tested with a SYBR premix ExTaqTM II kit,
a quantitative real time PCR reaction mixture composed of 5 μ l of SYBR, 0.2 μ l of forward-primers, 0.2 μ l
of reverse –primers, 3 μ l of mtDNA template and 1.6 μ l of water. The cycling was performed as follows:
the initial DNA denaturing step at 95 °C for 10 s followed by 40 cycles, each consisting of denaturation
at 95 °C for 5 s and primer annealing at 60 °C for 31 s. The following primer designs were used. The gene
segments of ND1 (mtDNA housekeeping genes) was the highly conservative sequence and revealed the
total mtDNA in the DNA patterns. The primers, ND1-F 5′ - GGCTACATACAATTACGCAAAG -3′ and
ND1-R 5′ - TAGAATGGAGTAGACCGAAAGG -3′ , were designed for the assay. After the purification
and separation of the PCR product, the internal standard curve was generated from 10-fold dilutions of
the standard substance according to the 1 ng PCR products.
Statistical analysis. In this study, power calculations were performed for the TEM and real time
PCR experiments to detect an adequate sample size using the PASS statistical package, version 11. For
the TEM experiments, the sample size of approximately 20 patients achieve 100% power to detect the
differences between the endometriosis and control groups with a significance level (alpha) of 0.05. For
the real time PCR experiments, the sample size of approximately 16 patients achieves 100% power to
detect the differences between the endometriosis and control groups with a significance level (alpha) of
0.05. Because our variable was an ordinal level, a statistical analysis of the TEM and real time PCR results
was performed with the SPSS, version 13 statistical package. The data were presented as the mean ± sd
and compared between the experimental groups with a t-test. The rates between the groups were com-
pared using the Chi square test and Fisher’s exact test when appropriate, and P < 0.05 was considered
significant.
Results
Basic clinical information. In the comparison of the endometriosis and control groups, no signif-
icant differences were observed regarding the age, duration of infertility, days of ovarian stimulation,
doses of gonadotropins applied and concentration of E2, LH, and progestational (P) on the day of HCG
(Table 1).
Ultrastructure of the oocytes. The TEM showed that the cumulus cells had abundant organelles
and that the cytoplasm of these cells in the endometriosis and control groups had identical bacilli form
mitochondria with tubular and/or villiform cristae. The nuclei predominantly contained decentralized
chromatin and a voluminous nucleolus (Fig. 1A,B). No difference regarding the density of the filamen-
tous texture of the inner aspect of the zona pellucida (ZP) was observed in the groups (Fig. 2A,B). The
oocytes were surrounded by an integrated and regularly structured plasma membrane provided with
numerous microvilli stretching into a perivitelline space (PVS) that appeared to be normal in terms of
Parameter Group
Control Group
Age (year, mean ± std) 30.31 ± 4.13
Duration of infertility (year,
mean ± std) 4.92 ± 2.15
bFSH (IU/L, mean ± std) 7.23 ± 2.89
bLH (IU/L, mean ± std) 4.34 ± 1.81
bE2 (pg/ml, mean ± std) 45.46 ± 19.42
bPRL (ng/ml, mean ± std) 14.91± 6.27
Days of ovarian stimulation
(mean ± std) 11.93 ± 2.19
Total of Gn doses (IU/L,
mean ± std) 2252.47 ± 828.42
E2 on HCG day (pg/ml,
mean ± std) 2412.24 ± 1379.56
LH on HCG day (IU/L, mean ± std) 1.14 ± 0.88
P on HCG day (ng/ml, mean ± std) 1.38 ± 0.12
Table 1. Basic information. P < 0.05 was considered statistically significant.
www.nature.com/scientificreports/
4
Scientific RepoRts | 5:10779 | DOi: 10.1038/srep10779
the shape, width and content (Fig. 2C,D). There were no differences in the morphology and electron
density of the cortical granule, Golgiapparatus and spindles between the groups (data not shown here).
In the oocytes of the control group, spherical or elliptical shaped mitochondria were well distributed
in the cytoplasm, and arc-like or transverse cristae were irregularly placed on the periphery and parallel
Figure 1. Cumulus cell of the oocytes in the endometriosis and control groups. The cumulus cells from
the control group show the same ultrastructural cytoplasmic characteristics of the cumulus cells surrounding
the oocytesas in the endometriosis group ( A,B). The tubular cristae of the mitochondria (arrows) are well
developed and evenly distributed. N = nuclei; M = mitochondria; Scale bar ( A,B) = 500 nm.
Figure 2. The electron density of the zona pellucida (A,B) and perivitelline space (C,D) in the
endometriosis and control groups, respectively. No difference was observed between the endometriosis
and control groups in the dense appearance of the inner aspect of the ZP , and some fibres are visible in the
zona texture (A,B). The microvilli (arrows) are numerous and long on the oolemma of both groups ( C,D).
MV = microvilli; PVS = perivitelline space; O = oocyte. Scale bar = 500 nm.
www.nature.com/scientificreports/
5
Scientific RepoRts | 5:10779 | DOi: 10.1038/srep10779
to the outer mitochondrial membrane (Fig. 3A). In the cytoplasm of the oocytes from the women with
minimal or mild endometriosis, numerous abnormal mitochondria (Fig. 3B–D), which contained small
or swollen and blurred vacuoles, were detected. In addition, the percentage of abnormal mitochondria
significantly increased in the oocytes of the endometriosis group compared with that of the control group
(Fig. 3E). The mass of the mitochondria in the cytoplasm of the oocytes was altered in the endometriosis
group (Fig. 4A,B). The relative number of mitochondria within the cytoplasm was significantly decreased
in the oocytes from women with minimal or mild endometriosis (Fig. 4C).
Figure 3. Ultrastructural differences in the mitochondria of normal oocytes and oocytes with
endometriosis. Mitochondria with typical tubular cristae are visible in the control cytoplasm ( A). A large
degree of vacuolization (arrows) could be seen in the mitochondria of the endometriosis group ( B-D).
The rate of abnormal mitochondria was significantly lower in the control group ( E). M = Mitochondria;
AM = abnormal mitochondria; Scale bar ( A,B,C,D) = 500 nm.The bars indicate the standard deviation (SD)
of the mean. *: compared with those of the control group, the abnormal mitochondria are significantly
(P < 0.05) increased in the oocytes from the endometriosis group. Note: Abnormal mitochondria rate = the
number of abnormal mitochondria/total number of mitochondria.
Figure 4. Comparison of the mitochondrial mass in the cytoplasm of the normal oocytes and the
oocytes from the endometriosis group. The electron micrograph of the oocytes in the control group
revealed abundant mitochondria in the cytoplasm ( A). However, the number of mitochondria was
significantly reduced in the endometriosis group ( B). There were significant differences between the two
groups regarding the mass of the mitochondria in cytoplasm ( C). The bars indicate the standard deviation
(SD) of the mean. *: compared with that of the control group, the number of mitochondria is significantly
(P < 0.05) low in the oocytes from the endometriosis group. Note: Mitochondria mass = number of
mitochondria/section. For each oocyte, the numbers of mitochondria were counted in at least 3 randomly
selected TEM-oocyte sections. To eliminate errors in the mitochondria identification and counting, all of the
analyses were performed in a double-blind manner by two or three individuals, and the data were pooled.
www.nature.com/scientificreports/
6
Scientific RepoRts | 5:10779 | DOi: 10.1038/srep10779
The detection of mitochondria DNA (mtDNA) copies. To ensure the decrease of the mitochon-
dria mass in the oocytes of the endometriosis group, the number of mitochondria was determined by
analysing the mtDNA copies. Thus, quantitative real time PCR was performed to analyse the number of
mtDNA copies per oocyte from the endometriosis and control group. The control group consisted of 18
mature oocytes (MII) collected from 15 patients with a mean mtDNA copy number of 84,657 ± 39,872
(Table 2). For the 19 mature oocytes of 16 patients from the endometriosis group, the mean mtDNA copy
number was 50,781 ± 28,569, which indicated a significantly different mtDNA copy number between the
two groups (P < 0.05)(Table 2).
Discussion
Endometriosis affects a large number of women of reproductive age 17, and many infertile women
with endometriosis select IVF to improve their chances of achieving a pregnancy. Several studies have
reported that the rate of fertilization was reduced during IVF/ICSI cycles in patients with minimal or
mild endometriosis compared with that of the patients with tubal-factor infertility
7,11,18. The mechanism
by which endometriosis affects the fertilization rate remains unclear. Infertility in women with endome-
triosis has been reported to be associated with alterations in normal pelvic anatomy, disturbed hormonal
support, ovulation dysfunction and disruption of the development of follicles, oocytes and embryos
19,20.
Among the factors associated with infertility in women with endometriosis, the oocyte quality is the
most important because it directly reflects the intrinsic developmental potential and is responsible for
normal fertilization/embryonic development during IVF . Poor oocyte quality could be the key reason
for adverse pregnancy outcomes during IVF/ICSI cycles in women with minimal or mild endometriosis.
Until now, the association between endometriosis and oocyte quality has been detected primarily by
clinical data analysis. The IVF-ET cycles in women with endometriosis have been reported to have, in
general, a low number of oocytes and decreased fertilization rate
21–24. The good embryo rate has been
reported to be reduced in the women with endometriosis after stimulated and/or unstimulated cycles
of IVF25,26. Navarro et al. reported that the implantation rates of oocytes from donors with endometrio-
sis were reduced in recipients without endometriosis 27. However, the effect of endometriosis on oocyte
morphology has received limited attention. By spindle imaging, Rajani et al. suggested that women with
endometriosis have oocytes with normal meiotic spindles
28. Mansour et al. documented the morpholog-
ical characteristics of oocytes by confocal imaging in women with endometriosis and reported abnor -
mal meiotic spindles and chromosomal misalignment 11. In our study, based on the ultrastructural and
quantitative real time PCR analysis of oocytes from patients with or without minimal or mild endome-
triosis, we have reported that the quality of these oocytes was decreased significantly, possibly because
of the alteration of the follicular microenvironment affecting oocyte development and maturation
29–31.
Mitochondria are double-membrane organelles that play a crucial role in the cell 32; they are considered
to be the powerhouses of the cells and to be involved in diverse signalling pathways and intracellular
processes, including regulation of intracellular redox potential, Ca 2+ handling and signalling, media-
tion of cellular and organismal aging and control of apoptosis 33,34. Mitochondria are hypothesized to
be derived exclusively from oocytes, and their activities appear to be essential for oocyte maturation,
chromosome segregation and the capacity of a high level of development
35. Several studies have indi-
cated that mitochondrial abnormalities and/or dysfunction could have an adverse influence on human
embryonic developmental and might affect competence for the fertilization of human oocytes
36–38. In
addition, endometriosis lesions, or its secretary products, could result in mitochondria of poorer quality
in oocytes, which would affect fertilization and implantation
7. Therefore, we suggest that minimal or mild
endometriosis is specifically linked to the occurrence of impaired mitochondrial structure and reduced
mtDNA copy numbers because of disorders of cytoplasmic maturation.
In our study, the mtDNA copy number was decreased significantly in the oocytes of women with
minimal or mild endometriosis in comparison to that of the control group (Table 2). Mitochondrial DNA
is present in the mitochondrion and in the codes for proteins that are indispensable for cellular energy
production
39.Typically, a normal MII oocyte contains approximately 10 5 mitochondria in human 40, and
the mtDNA copy numbers could directly represent the mitochondria mass and function 39,40. The low
mtDNA content might imply that perturbed oogenesis might be the primaryabnormality responsible for
poor oocyte quality. Poor energy production could be linked to insufficient mitochondrial biogenesis and
oocyte maturation39. Mitochondria with mtDNA that possesses a common deletion are more pervasive in
arrested or degenerated oocytes 41. Additionally, these reports have suggested that mitochondria-related
Group No. of oocytes Mean minimum Maximum
Control 19 84,657 ± 39,872 31,100 255,300
Endometriosis 18 50,781 ± 28,569* 26,900 132,500
Table 2. Mitochondrial DNA copy number for the oocytes from the two groups. Note: The values are the
means ± SD. * P < 0.05 vs. the control group.
www.nature.com/scientificreports/
7
Scientific RepoRts | 5:10779 | DOi: 10.1038/srep10779
poor oocyte quality is associated with adverse outcomes in IVF/ICSI cycles with minimal or mild endo-
metriosis.
In this study, we examined, by TEM, the oocyte quality in IVF patients with minimal or mild endo-
metriosis; to the best of our knowledge, TEM has not previously been used for investigating the asso-
ciation between oocyte quality and minimal or mild endometriosis. The oocytes from the patients with
minimal or mild endometriosis showed increased abnormal mitochondria and reduced mitochondria
mass, which suggested that the oocyte quality was decreased in oocytes from women with minimal or
mild endometriosis. Some methodological limitations should be noted. In this study, the estimate of the
oocyte quality was predominantly based on the ultrastructure analysis. Beyond that, evidence from other
aspects was not sufficient. Moreover, only patients with minimal or mild endometriosis were enrolled in
this study. For these reasons, these findings could not be generalized to the broader community based
on this study alone, and studies using more oocyte quality assessment methods and having patients with
different stages of endometriosis are necessary.
References
1. Rock, J. A. & Markham, S. M. Pathogenesis of endometriosis. Lancet 340, 1264–1267 (1992).
2. Ozkan, S., Murk, W . & Arici, A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann. N. Y. Acad.
Sci. 1127, 92–100 (2008).
3. Damewood, M. D. The role of the new reproductive technologies including IVF and GIFT in endometriosis. Obstet. Gynecol.
Clin. North. Am. 16, 179–191 (1989).
4. Harb, H. M., Gallos, I. D., Chu, J. & Harb, M., Coomarasamy, A. The effect of endometriosis on in vitro fertilisation outcome: a
systematic review and meta-analysis. BJOG 120, 1308–1320 (2013).
5. Hickman, T. N. Impact of endometriosis on implantation. Data from the Wilford Hall Medical Center IVF-ET Program. J.
Reprod. Med. 47, 801–808 (2002).
6. Suzuki, T. et al. Impact of ovarian endometrioma on oocytes and pregnancy outcome in in vitro fertilization. Fertil. Steril. 83,
908–913 (2005).
7. Barnhart, K., Dunsmoor-Su, R. & Coutifaris, C. Effect of endometriosis on in vitro fertilization. Fertil. Steril. 77, 1148–1155
(2002).
8. Bergendal, A. et al. Outcome of IVF in patients with endometriosis in comparison with tubal-factor infertility. J. Assist. Reprod.
Genet. 15, 530–534 (1998).
9. Lyons R. A. et al. Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube. Lancet 360, 1221–1222
(2002).
10. Garrido N. et al. Follicular hormonal environment and embryo quality in women with endometriosis. Hum. Reprod. Update 6,
67–74 (2000).
11. Mansour, G., Sharma, R. K., Agarwal, A. & Falcone, T. Endometriosis-induced alterations in mouse metaphase II oocyte
microtubules and chromosomal alignment: a possible cause of infertility. Fertil. Steril. 94, 1894–1899 (2010).
12. Gleicher, N., el-Roeiy, A., Confino, E. & Friberg, J. Is endometriosis an autoimmune disease? Obstet. Gynecol. 70, 115–122 (1987).
13. Matalliotakis, I. M. et al. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin
stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility. Fertil. Steril.
88, 1568–1572 (2007).
14. Arici, A. et al. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation
of expression in mesothelial cells. Fertil. Steril. 67, 1065–1072 (1997).
15. Garrido, N., Pellicer, A., Remohi, J. & Simon, C. Uterine and ovarian function in endometriosis. Semin. Reprod. Med. 21, 183–192
(2003).
16. Nottola, S. A. et al. Ultrastructural markers of quality in human mature oocytes vitrified using cryoleaf and cryoloop. Reprod.
Biomed. Online 19 Suppl 3, 17–27 (2009).
17. Marcoux, S., Maheux, R. & Berube, S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian
Collaborative Group on Endometriosis. N. Engl. J. Med. 337, 217–222 (1997).
18. Opøien, H. K. et al. In vitro fertilization is a successful treatment in endometriosis-associated infertility. Fertil. Steril. 97, 912–8
(2012).
19. Harlow, C. R. et al. Reduced preovulatory granulosa cell steroidogenesis in women with endometriosis. J. Clin. Endocrinol. Metab.
81, 426–429 (1996).
20. Toya, M. et al. Hiroi M. Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in
patients undergoing in vitro fertilization and embryo transfer. Fertil. Steril. 73, 344–350 (2000).
21. Al-Fadhli, R., Kelly, S. M., Tulandi, T. & Tanr, S. L. Effects of differentstages of endometriosis on the outcome of in vitro
fertilization. JObstet. Gynaecol. Can. 28, 888–891 (2006).
22. Bergqvist, A. & D’Hooghe, T. Mini symposium on pathogenesis ofendometriosis and treatment of endometriosis-associated
subfertility. Introduction: the endometriosis enigma. Hum. Reprod. Update 8, 79–83 (2002).
23. Kumbak, B. et al. Invitro fertilization in normoresponder patients with endometriomas: comparison with basal simple ovarian
cysts. Gynecol ObstetInvest. 65, 212–216 (2008).
24. Mahutte, N. G. & Arici, A. Endometriosis and assisted reproductivetechnologies: are outcomes affected? Curr. Opin. Obstet.
Gynecol. 13, 275–279 (2001).
25. Cahill, D. J. & Hull, M. G. Pituitary-ovarian dysfunction and endometriosis. Hum. Reprod. Update 6, 56–66 (2000).
26. Hull, M. G. et al. The contribution of subtle oocyte or sperm dysfunctionaffecting fertilization in endometriosis-associated or
unexplainedinfertility: a controlled comparison with tubal infertility and use ofdonor spermatozoa. Hum. Reprod. 13, 1825–1830
(1998).
27. Navarro, J., Garrido, N., Remohi, J. & Pellicer, A. How does endometriosis affect infertility? Obstet. Gynecol. Clin. North. Am. 30,
181–192 (2003).
28. Rajani, S. et al. Assessment of oocyte quality in polycystic ovarian syndrome and endometriosis by spindle imaging and reactive
oxygen species levels in follicular fluid and its relationship with IVF-ET outcome. J. Hum. Reprod. Sci. 5, 187–93 (2012).
29. Lessey, B. A. et al. Aberrant integrin expression in the endometrium of women with endometriosis. J. Clin. Endocrinol. Metab.
79, 643–649 (1994).
30. Lessey, B. A. Medical management of endometriosis and infertility. Fertil. Steril. 73, 1089–1096 (2000)
31. Lucena, E. & Cubillos, J. Immune abnormalities in endometriosis compromising fertility in IVF-ET patients. J. Reprod. Med. 44,
458–464 (1999).
32. Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482–1488 (1999).
www.nature.com/scientificreports/
8
Scientific RepoRts | 5:10779 | DOi: 10.1038/srep10779
33. Balaban, R. S., Nemoto, S. & Finkel T. Mitochondria, oxidants, and aging. Cell 120, 483–495 (2005).
34. Dumollard, R., Duchen, M. & Carroll J. The role of mitochondrial function in the oocyte and embryo. Curr. Top. Dev. Biol. 77,
21–49 (2007).
35. Eichenlaub-Ritter, U., Wieczorek, M., Luke, S. & Seidel, T. Age related changes in mitochondrial function and new approaches
to study redox regulation in mammalian oocytes in response to age or maturation conditions. Mitochondrion 11, 783–796 (2011).
36. Au, H. K. et al. Abnormal mitochondrial structure in human unfertilized oocytes and arrested embryos. Ann. N. Y. Acad. Sci.
1042, 177–185 (2005).
37. Motta, P . M., Nottola, S. A., Makabe, S. & Heyn, R. Mitochondrial morphology in human fetal and adult female germ cells. Hum.
Reprod. 15 Suppl 2, 129–147 (2000).
38. Van, Blerkom J. Mitochondria in human oogenesis and preimplantation embryogenesis, engines of metabolism, ionic regulation
and developmental competence. Reproduction 128, 269–280 (2004).
39. May-Panloup, P ., Chretien, M. F ., Malthiery, Y . & Reynier, P . Mitochondrial DNA in the oocyte and the developing embryo. Curr.
Top. Dev. Biol. 77, 51–83 (2007).
40. Chen X. et al. Rearranged mitochondrial genomes are present in human oocytes. Am. J. Hum. Genet. 57, 239–247 (1995).
41. Steuerwald, N., Cohen, J., Herrera, R. J. & Brenner, C. A. Quantification of mRNA in single oocytes and embryos by real-time
rapid cycle fluorescence monitored RT-PCR. Mol. Hum. Reprod. 6, 448–453 (2000).
Acknowledgments
The authors thank Dr. Wen Hu for Electron Microscopy Techniques. This research was supported by
the Natural Science Foundation of Anhui Provincial of China (1308085QH131, 1408085MH150), the
National Natural Science Foundation of China (81370757), and Natural Science Research Project of
Anhui Provincial Education Department (KJ2013Z134).
Author Contributions
B.X. and Y .L. conceived the idea and coordinated the project. B.X., N.G., X.Z. and W .S. collected data
and performed the experiments. B.X., N.G., W .S. and X.T. analyzed the results. B.X. and F .I. wrote the
manuscript.
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Xu, B. et al. Oocyte quality is decreased in women with minimal or mild
endometriosis. Sci. Rep. 5, 10779; doi: 10.1038/srep10779 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from the license holder to reproduce
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.